KR100499214B1 - 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자 - Google Patents

아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자 Download PDF

Info

Publication number
KR100499214B1
KR100499214B1 KR10-2000-7008870A KR20007008870A KR100499214B1 KR 100499214 B1 KR100499214 B1 KR 100499214B1 KR 20007008870 A KR20007008870 A KR 20007008870A KR 100499214 B1 KR100499214 B1 KR 100499214B1
Authority
KR
South Korea
Prior art keywords
avec
delete delete
streptomyces avermitilis
avermectin
streptomyces
Prior art date
Application number
KR10-2000-7008870A
Other languages
English (en)
Korean (ko)
Other versions
KR20010052166A (ko
Inventor
스투츠만-엔그월킴조넬
가토요시히로
맥아써하미쉬알라스테어어빈
Original Assignee
화이자 프로덕츠 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 프로덕츠 인코포레이티드 filed Critical 화이자 프로덕츠 인코포레이티드
Publication of KR20010052166A publication Critical patent/KR20010052166A/ko
Application granted granted Critical
Publication of KR100499214B1 publication Critical patent/KR100499214B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR10-2000-7008870A 1998-02-13 1999-01-25 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자 KR100499214B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13
US60/074,636 1998-02-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7008310A Division KR20040053390A (ko) 1998-02-13 1999-01-25 아베르멕틴의 비2:비1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자

Publications (2)

Publication Number Publication Date
KR20010052166A KR20010052166A (ko) 2001-06-25
KR100499214B1 true KR100499214B1 (ko) 2005-07-07

Family

ID=22120706

Family Applications (3)

Application Number Title Priority Date Filing Date
KR10-2000-7008870A KR100499214B1 (ko) 1998-02-13 1999-01-25 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자
KR10-2004-7015691A KR20040099389A (ko) 1998-02-13 1999-01-25 스트렙토마이세스 하이그로스코피쿠스 유전자
KR10-2004-7008310A KR20040053390A (ko) 1998-02-13 1999-01-25 아베르멕틴의 비2:비1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR10-2004-7015691A KR20040099389A (ko) 1998-02-13 1999-01-25 스트렙토마이세스 하이그로스코피쿠스 유전자
KR10-2004-7008310A KR20040053390A (ko) 1998-02-13 1999-01-25 아베르멕틴의 비2:비1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자

Country Status (32)

Country Link
EP (1) EP1053335A1 (no)
JP (2) JP2002503473A (no)
KR (3) KR100499214B1 (no)
CN (2) CN1521180A (no)
AP (1) AP9901463A0 (no)
AR (1) AR018085A1 (no)
AU (1) AU752343C (no)
BG (1) BG64911B1 (no)
BR (1) BR9907893A (no)
CA (2) CA2521289A1 (no)
CO (1) CO5070698A1 (no)
DZ (1) DZ2720A1 (no)
EA (1) EA003905B1 (no)
GT (1) GT199900014A (no)
HN (1) HN1999000008A (no)
HR (1) HRP20000539A2 (no)
HU (1) HUP0100784A3 (no)
IL (2) IL137610A0 (no)
IS (1) IS5567A (no)
MA (1) MA24760A1 (no)
NO (1) NO20004044L (no)
NZ (2) NZ505676A (no)
OA (1) OA11449A (no)
PA (1) PA8467601A1 (no)
PE (1) PE20000352A1 (no)
PL (1) PL194270B1 (no)
SK (1) SK11722000A3 (no)
TN (1) TNSN99017A1 (no)
TW (1) TW585910B (no)
WO (1) WO1999041389A1 (no)
YU (1) YU50900A (no)
ZA (1) ZA991138B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1521180A (zh) * 1998-02-13 2004-08-18 �Ʒ� 介导除虫菌素b2:b1比例的除虫链霉菌基因
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
WO2001012821A1 (en) * 1999-08-12 2001-02-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
JP2005517406A (ja) * 2002-02-12 2005-06-16 ファイザー・プロダクツ・インク B2:B1アベルメクチン比を支配するStreptomycesavermitilis遺伝子
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900004419A (ko) * 1988-09-20 1990-04-12 아오이 죠이찌 압연기의 롤갭설정방법 및 장치
EP0445460A1 (en) * 1990-03-05 1991-09-11 The Kitasato Institute A microorganism for selective production of a specific component of avermectin and a method for selective production thereof
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
WO1999041389A1 (en) * 1998-02-13 1999-08-19 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (no) * 1987-01-23 1991-01-19 Pfizer
EP0313297B1 (en) * 1987-10-23 1993-05-19 Pfizer Inc. Process for production of avermectin aglycones and cultures therefor
NZ233116A (en) * 1989-03-31 1994-09-27 Merck & Co Inc Cloning genes from steptomyces avermitilis for avermectin biosynthesis
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900004419A (ko) * 1988-09-20 1990-04-12 아오이 죠이찌 압연기의 롤갭설정방법 및 장치
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
EP0445460A1 (en) * 1990-03-05 1991-09-11 The Kitasato Institute A microorganism for selective production of a specific component of avermectin and a method for selective production thereof
WO1999041389A1 (en) * 1998-02-13 1999-08-19 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
(13쪽, 요약문) (과기처 Avermectin 생산균주의 분자유전학적 육종 연구보고서 1996.10 *
J Antibiot (Tokyo) 1995 Jan;48(1):95-7 *
J Antibiot (Tokyo) 1995 Jul;48(7):549-62 *
J Bacteriol 1993 May;175(9):2552-63 *
J Bacteriol 1995 Jun;177(12):3504-11 *
The journal of Antibiotics vol.48 no 6, 1995년 P532-34 *

Also Published As

Publication number Publication date
BG64911B1 (bg) 2006-08-31
EA200000758A1 (ru) 2001-04-23
PA8467601A1 (es) 2000-09-29
JP4011036B2 (ja) 2007-11-21
PE20000352A1 (es) 2000-05-16
HN1999000008A (es) 1999-10-29
AU752343B2 (en) 2002-09-19
CA2320031A1 (en) 1999-08-19
CN1297485A (zh) 2001-05-30
IL137610A0 (en) 2001-07-24
BR9907893A (pt) 2000-11-14
HRP20000539A2 (en) 2001-04-30
SK11722000A3 (sk) 2001-04-09
KR20040053390A (ko) 2004-06-23
AP9901463A0 (en) 1999-03-31
AR018085A1 (es) 2001-10-31
BG104759A (en) 2001-04-30
TNSN99017A1 (fr) 2005-11-10
KR20010052166A (ko) 2001-06-25
TW585910B (en) 2004-05-01
CN1521180A (zh) 2004-08-18
CO5070698A1 (es) 2001-08-28
JP2002503473A (ja) 2002-02-05
NZ505676A (en) 2003-02-28
AU752343C (en) 2005-11-03
IS5567A (is) 2000-07-20
EP1053335A1 (en) 2000-11-22
YU50900A (sh) 2004-03-12
PL194270B1 (pl) 2007-05-31
IL183596A0 (no) 2007-09-20
AU1887899A (en) 1999-08-30
HUP0100784A3 (en) 2004-10-28
EA003905B1 (ru) 2003-10-30
WO1999041389A1 (en) 1999-08-19
GT199900014A (es) 2000-07-25
OA11449A (en) 2003-12-03
PL342468A1 (en) 2001-06-04
MA24760A1 (fr) 1999-10-01
KR20040099389A (ko) 2004-11-26
CA2521289A1 (en) 1999-08-19
HUP0100784A2 (hu) 2001-06-28
ZA991138B (en) 2000-08-14
JP2004283174A (ja) 2004-10-14
DZ2720A1 (fr) 2003-09-01
NZ518657A (en) 2003-10-31
NO20004044L (no) 2000-10-11
NO20004044D0 (no) 2000-08-11

Similar Documents

Publication Publication Date Title
JP2005198658A (ja) B2:B1アベルメクチン比率を支配するStreptomycesavermitilis遺伝子
KR100499214B1 (ko) 아베르멕틴의 b2:b1의 비를 제어할 수 있는 스트렙토마이세스 아베르미틸리스 유전자
KR100489856B1 (ko) B2:b1 아베르멕틴의 비율을 제어하는 스트렙토마이세스아베르미틸리스 유전자
KR100718378B1 (ko) B2:b1 아베르멕틴의 비를 제어하는 스트렙토마이세스아베르미틸리스 유전자
MXPA00007915A (en) I(streptomyces avermitilis) gene directing the ratio of b2:b1 avermectins

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
A107 Divisional application of patent
AMND Amendment
E902 Notification of reason for refusal
E902 Notification of reason for refusal
B701 Decision to grant
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee